Recent publications
Article
Bryan, R, Liu, W, Pirrie, S, Amir, R, Gallagher, J, Hughes, A, Jefferson, K, Knight, A, Nanton, V, Mintz, H, Pope, A, Catto, J, Patel, P & James, N 2021, 'Comparing an imaging-guided pathway with the standard pathway for staging muscle-invasive bladder cancer: preliminary data from the BladderPath study', European urology. https://doi.org/10.1016/j.eururo.2021.02.021
Dowell, A, Munford, H, Goel, A, Gordon, N, James, N, Cheng, KK, Zeegers, M, Ward, D & Bryan, R 2021, 'PD-L2 is constitutively expressed in normal and malignant urothelium', Frontiers in Oncology.
Kibaru, J, Kotecha, P, Iya, AM, Russell, B, Abdullahi, M, Alhassan, SU, Mustapha, MI, Bryan, R & Van Hemelrijck, M 2021, 'Scoping Review protocol: Bladder cancer in Nigeria - what are the gaps in clinical care and research?', BMJ open, vol. 2021, no. 11, e041894. https://doi.org/10.1136/bmjopen-2020-041894
Russell, B, Haggstrom, C, Holmberg, L, Liedberg, F, Gårdmark, T, Bryan, R, Kumar, P & Van Hemelrijck, M 2021, 'Systematic review of the association between socioeconomic status and bladder cancer survival with hospital type, comorbidities, and treatment delay as mediators', BJUI Compass. https://doi.org/10.1002/bco2.65
Bessa, A, Rammant, E, Enting, D, Bryan, R, Khan, MS, Malde, S, Nair, R, Thurairaja, R, Cahill, F, Amery, S, Smith, S, Ahmed, K, Russell, B, Moss, C, Chatterton, K, Haggstrom, C & Van Hemelrijck, M 2021, 'The need for supportive mental wellbeing interventions in bladder cancer patients: a systematic review of the literature', PLoS ONE, vol. 16, no. 1, e0243136. https://doi.org/10.1371/journal.pone.0243136
Birtle, A, Johnson, M, Chester, J, Jones, R, Dolling, D, Bryan, R, Harris, C, WInterbottom, A, Blacker, A, Catto, J, Chakraborti, P, Donovan, J, Elliott, P, French, A, Jagdev, S, Jenkins, B, Keeley, F, Kockelbergh, R, Powles, T, Wagstaff, J, Wilson, C, Todd, R, Lewis, R & Hall, E 2020, 'Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial', The Lancet, vol. 395, no. 10232, pp. 1268-1277. https://doi.org/10.1016/S0140-6736(20)30415-3
Goel, A, Ward, D, Gordon, N, Abbotts, B, Zeegers, M, Cheng, KK, James, N, Bryan, R & Arnold, R 2020, 'Back-splicing transcript isoforms (circular RNAs) affect biologically relevant pathways and offer an additional layer of information to stratify NMIBC patients', Frontiers in Oncology, vol. 10, 812. https://doi.org/10.3389/fonc.2020.00812
Mintz, H, Dosanjh, A, Parsons, H, Hughes, A, Jakeman, A, Pope, A, Bryan, R, James, N & Patel, P 2020, 'Development and validation of a follow-up methodology for a randomised controlled trial, utilising routine clinical data as an alternative to traditional designs: a pilot study to assess the feasibility of use for the BladderPath trial', Pilot and Feasibility Studies, vol. 6, 165. https://doi.org/10.1186/s40814-020-00713-y
Jochems, S, Reulen, R, Van Osch, F, Witlox, WJA, Goossens, ME, Brinkman, M, Giles, GG, Milne, RL, van den Brandt, PA, White, E, Weiderpass, E, Huybrechts, I, Hémon, B, Agudo, A, Bueno-de-Mesquita, B, Cheng, KK, van Schooten, FJ, Bryan, R, Wesselius, A & Zeegers, M 2020, 'Fruit consumption and the risk of bladder cancer: a pooled analysis by the BLadder cancer Epidemiology and Nutritional Determinants study', International Journal of Cancer. https://doi.org/10.1002/ijc.33008
Lipunova, N, Wesselius, A, Cheng, KK, van Schooten, F-J, Bryan, RT, Cazier, J-B & Zeegers, MP 2020, 'Gene-environment interaction with smoking for increased non-muscle-invasive bladder cancer tumor size', Translational Andrology and Urology, vol. 9, no. 3, pp. 1329-1337. https://doi.org/10.21037/tau-19-523
Kourbanhoussen, K, McMartin, C, Lodde, M, Zlotta, A, Bryan, R & Toren, P 2020, 'Switching cancers: a systematic review assessing the role for androgen suppressive therapy in bladder cancer', European Urology Focus. https://doi.org/10.1016/j.euf.2020.10.002
Bryan, RT & POUT Trial Management Group 2020, 'The implementation and utility of patient screening logs in a multicentre randomised controlled oncology trial', Trials, vol. 21, no. 1, 629. https://doi.org/10.1186/s13063-020-04559-w
Editorial
Ward, DG, Arnold, R & Bryan, RT 2020, 'Molecular subtypes of T1 bladder cancer: biomolecular characteristics versus clinical utility', European urology, vol. 78, no. 4, pp. 538-539. https://doi.org/10.1016/j.eururo.2020.07.021
Letter
Spencer-Bowdage, S, Russell, B, Rigby, J, O'Kelly, J, Kelly, P, Page, M, Raw, C, Allchorne, P, Harper, P, Crew, J, Kockelbergh, R, Knight, A, Van Hemelrijck, M & Bryan, R 2021, 'The experience of UK bladder cancer patients during the COVID-19 pandemic: a survey-based snapshot', BJU International , vol. 127, no. 2, pp. 179-181. https://doi.org/10.1111/bju.15287
Other contribution
Lipunova, N, Bryan, RT & Zeegers, MP 2020, Bilirubin is not associated with urinary bladder cancer risk and prognosis: A Mendelian Randomization Study in the UK Biobank.. https://doi.org/10.1101/2020.08.13.20174102
View all publications in research portal